Skip to content

Chronic migraine

Chronic migraine is one of the most visible therapeutic indications for botulinum toxin type A, especially through Botox.

This indication is strategically important because it shows that botulinum toxin is not limited to movement disorders or aesthetics. It expands the topic graph into neurology and pain management.

When chronic migraine is included in the seed graph, the site can connect toxin biology, therapeutic evidence, manufacturer strategy, and patient-facing interest within a single topic cluster.